Cui Xiangmin

CIK 00014878154 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001487815

Recent Transactions

39 trades

Sale
BeyondSpring Inc.$BYSI
Ordinary Shares
2025-09-08$1.93/sh−7,090→ 1,895,756 total
Sale
BeyondSpring Inc.$BYSI
Ordinary Shares
2025-09-05$1.86/sh−1,106→ 1,902,846 total
Sale
BeyondSpring Inc.$BYSI
Ordinary Shares
2025-09-04$1.82/sh−803→ 1,903,952 total
Conversion
Nuvation Bio Inc.$NUVB
Series A Preferred Stock
2024-09-04−128,792→ 0 total
Conversion
Nuvation Bio Inc.$NUVB
Series A Preferred Stock
2024-09-04−9,671→ 0 total
Conversion
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-09-04+12,879,200→ 17,062,202 total
Conversion
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-09-04+967,100→ 1,281,206 total
Conversion
Nuvation Bio Inc.$NUVB
Series A Preferred Stock
2024-09-04−51,579→ 0 total
Conversion
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-09-04+5,157,900→ 7,611,031 total
Award
Nuvation Bio Inc.$NUVB
Series A Preferred Stock
2024-09-03+9,671→ 9,671 total
Award
Nuvation Bio Inc.$NUVB
Warrants (Right to Buy)
2024-09-03+175,346→ 175,346 total
Award
Nuvation Bio Inc.$NUVB
Series A Preferred Stock
2024-09-03+128,792→ 128,792 total
Award
Nuvation Bio Inc.$NUVB
Warrants (Right to Buy)
2024-09-03+437,834→ 437,834 total
Award
Nuvation Bio Inc.$NUVB
Series A Preferred Stock
2024-09-03+51,579→ 51,579 total
Award
Nuvation Bio Inc.$NUVB
Warrants (Right to Buy)
2024-09-03+32,877→ 32,877 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-06-25$2.97/sh+277,895→ 2,453,131 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-06-24$2.98/sh+336,874→ 2,175,236 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-06-21$3.00/sh+75,411→ 1,838,362 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-06-20$2.99/sh+87,715→ 1,762,951 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−17,500→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition from Tender
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-18−6,582,380→ 0 total
Disposition from Tender
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-18−1,735,544→ 0 total
Award
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-04-09+314,106→ 314,106 total
Award
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-04-09+1,675,236→ 1,675,236 total
Award
Nuvation Bio Inc.$NUVB
Class A Common Stock
2024-04-09+4,183,002→ 4,183,002 total
Purchase
CG Oncology, Inc.$CGON
Common Stock
2024-01-29$19.00/sh+400,000→ 4,958,810 total
Conversion
CG Oncology, Inc.$CGON
Common Stock
2024-01-29+3,628,198→ 4,558,812 total
Purchase
CG Oncology, Inc.$CGON
Common Stock
2024-01-29$19.00/sh+400,000→ 400,000 total
Conversion
CG Oncology, Inc.$CGON
Series E Preferred Stock
2024-01-29−21,547,685→ 0 total
Conversion
CG Oncology, Inc.$CGON
Series C Preferred Stock
2024-01-29−8,644,891→ 0 total
Conversion
CG Oncology, Inc.$CGON
Series F Preferred Stock
2024-01-29−4,402,320→ 0 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-18$12.74/sh+1,234,636→ 6,582,380 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Warrant (right to buy)
2024-01-18−1,234,636→ 0 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-02+17,500→ 17,500 total

Companies

Recent Filings

Address

C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401

NEW YORK, NY, 10036

View on SEC.gov